Mechanical Insufflation-Exsufflation (MIE) for Cough Assist

Mechanical insufflation-exsufflation is an airway clearance therapy used to help patients who cannot cough effectively on their own. The therapy works by delivering positive pressure to help inflate the lungs, then rapidly switching to negative pressure to create a strong outward flow of air.

This sudden expiratory flow simulates a cough and helps move secretions toward the mouth or artificial airway, where they can be removed by expectoration or suctioning.

What Is Mechanical Insufflation-Exsufflation?

Mechanical insufflation-exsufflation (MIE) is a noninvasive or airway-connected method of producing an artificial cough. The device alternates between two pressure phases. First, it applies positive pressure to the airway to inflate the lungs. This is the insufflation phase. Then it quickly switches to negative pressure to pull air out of the lungs. This is the exsufflation phase.

The rapid change from positive to negative pressure creates high expiratory airflow. This flow helps shear mucus from the airway walls and move secretions from the lower airways toward the upper airway. Once secretions reach the upper airway, the patient may cough them out, spit them out, swallow them, or have them removed by suctioning.

MIE is most commonly associated with patients who have neuromuscular weakness, neurologic impairment, spinal cord injury, or other conditions that prevent an effective cough. It is not simply a mucus-loosening therapy. Its main purpose is to replace or strengthen the cough mechanism when the patient cannot generate enough inspiratory volume or expiratory force.

Why an Effective Cough Matters

Coughing is one of the body’s most important airway clearance mechanisms. It helps remove mucus, foreign material, and airway debris before they accumulate and cause complications. When a person has a strong cough, secretions can be moved out of the lower airways and cleared from the respiratory tract.

A normal cough has several phases. First, the person takes a deep breath. This deep inspiration increases lung volume and prepares the lungs for forceful exhalation. Next, the glottis closes briefly while the expiratory muscles contract. This creates pressure inside the chest. When the glottis opens, air rushes out rapidly. The high-speed airflow helps move secretions upward through the airways.

For this process to work well, the patient needs adequate inspiratory muscle strength, expiratory muscle strength, airway patency, and glottic function. If one or more of these components is impaired, cough becomes weak. A weak cough may not generate enough airflow to move secretions out of the lungs.

This can lead to secretion retention, airway obstruction, atelectasis, infection, impaired oxygenation, increased work of breathing, and ventilation-perfusion imbalance. In patients with chronic weakness, repeated episodes of poor secretion clearance can also contribute to pneumonia and worsening respiratory function.

How MIE Simulates a Cough

Mechanical insufflation-exsufflation is designed to imitate the pressure and flow changes of a natural cough. During insufflation, the machine delivers a positive-pressure breath through a face mask, mouthpiece, or artificial airway. This helps the lungs expand and provides the deep breath that the patient may not be able to take independently.

After the lungs are inflated, the device rapidly switches to negative pressure. This sudden pressure reversal pulls air out of the lungs and creates a strong expiratory flow. The fast outward movement of air mimics the forceful exhalation phase of a cough.

This is why MIE is often called cough assist. It assists both parts of the cough that are commonly impaired in neuromuscular disease: the ability to take a deep breath and the ability to exhale forcefully. By improving both inspiratory volume and expiratory flow, MIE helps move secretions toward the mouth or airway opening.

Common Indications for MIE

Mechanical insufflation-exsufflation is mainly indicated when a patient has retained secretions and cannot cough effectively. The therapy is especially useful in patients with neuromuscular or neurologic disorders that weaken the respiratory muscles.

Common conditions associated with MIE use include:

• Amyotrophic lateral sclerosis
• Spinal muscular atrophy
• Duchenne muscular dystrophy
• Myasthenia gravis
• Poliomyelitis
• Spinal cord injury
• Other chronic neuromuscular disorders
• Neurologic impairment with ineffective cough
• Long-term ventilatory support with poor secretion clearance

MIE may also be considered when conventional airway clearance methods are not enough. For example, positioning, directed cough, breathing control, manually assisted cough, chest physical therapy, positive expiratory pressure therapy, or suctioning may not fully clear secretions in a patient with severe muscle weakness. In that situation, MIE can provide the pressure-assisted cough needed to mobilize secretions more effectively.

Peak Cough Flow and Patient Selection

Patient selection is one of the most important parts of mechanical insufflation-exsufflation therapy. A key measurement is peak cough flow, which reflects how forcefully a patient can cough. Low peak cough flow suggests that the patient may not be able to clear secretions effectively.

For adults with neuromuscular disease, a peak cough flow less than 270 L/min is an important warning sign. This threshold is often used to identify patients who may need cough-assist techniques. A peak cough flow below 180 L/min is especially concerning because it suggests that the patient may not be able to generate an effective cough during illness or increased secretion production.

Some exam review sources also describe a bedside peak flow measurement as a practical equivalent for estimating cough strength. For example, a patient with neurologic weakness, retained secretions, and a peak flow of 200 L/min would be a strong candidate for mechanical insufflation-exsufflation.

Another useful measurement is maximal expiratory pressure. An MEP less than 60 cm H₂O suggests expiratory muscle weakness and poor cough ability. In patients with neuromuscular disease, a peak cough flow less than 270 L/min or an MEP less than 60 cm H₂O should prompt consideration of an airway clearance regimen such as manually assisted cough or MIE.

MIE in Neuromuscular Disease

Mechanical insufflation-exsufflation is especially important in neuromuscular disease because these patients often lose cough strength before they lose all ventilatory ability. A patient may still be able to breathe adequately at rest but may not be able to clear secretions during infection, fatigue, or increased mucus production.

In neuromuscular disease, weak inspiratory muscles may prevent the patient from taking a deep breath before coughing. Weak expiratory muscles may prevent the patient from generating the force needed to expel mucus. When both problems are present, secretions can remain in the airways and contribute to atelectasis, pneumonia, and respiratory failure.

MIE can help by providing a deep insufflation followed by a forceful exsufflation. This can improve secretion movement and reduce the risk of complications related to retained mucus. In patients with progressive neuromuscular disorders, caregivers may also be trained to use cough-assist therapy as part of the patient’s home airway clearance plan.

However, MIE does not replace ventilatory support when the main problem is chronic hypoventilation. For example, a patient with neuromuscular weakness may use MIE successfully for secretion clearance but still require noninvasive ventilation or invasive ventilation if PaCO₂ rises, vital capacity declines, orthopnea develops, or daytime sleepiness appears. MIE helps clear secretions, while ventilatory support helps correct inadequate ventilation.

MIE in Spinal Cord Injury

Patients with spinal cord injury may also benefit from MIE, especially when injury affects the muscles needed for coughing. High spinal cord injuries can impair expiratory muscle function and reduce the ability to generate forceful airflow. As a result, secretions may accumulate and increase the risk of atelectasis and pneumonia.

In the chronic phase of spinal cord injury care, respiratory goals often include preventing atelectasis, reducing pneumonia risk, improving quality of life, and supporting airway clearance. Caregivers may be taught manual assisted cough techniques, such as the quad cough, but some patients need additional support from a mechanical insufflation-exsufflation device.

MIE may be especially helpful when the patient has bronchitis, retained secretions, neurologic impairment, and a low peak cough flow. In these cases, a cough-assist device can provide the inspiratory and expiratory flow changes needed to move secretions out of the airway.

MIE in Pediatric Care

Mechanical insufflation-exsufflation can also be used in pediatric patients, particularly children with neuromuscular disorders such as spinal muscular atrophy. These patients may have weak respiratory muscles, ineffective cough, and increased dependence on noninvasive ventilation during illness.

In a pediatric airway clearance plan, MIE may be used with carefully selected settings based on the child’s size, condition, tolerance, and clinical response. Treatment may include several insufflation-exsufflation cycles followed by suctioning. The cycle may be repeated until secretions are cleared and breath sounds, aeration, oxygenation, and ventilatory needs improve.

Pediatric use requires careful monitoring because children may be more sensitive to pressure changes, fatigue, air leaks, and changes in oxygen saturation. As with adult patients, the goal is not simply to apply a preset pressure. The goal is to improve secretion clearance safely and effectively.

Equipment Used for MIE

A mechanical insufflation-exsufflation system generally includes a main control unit, compressor, tubing, filter, and patient interface. The device allows the clinician to set pressure levels, inspiratory time, expiratory time, pause time, flow settings, and operating mode.

Patient interfaces may include:

• Oronasal mask
• Face mask
• Mouthpiece
• Tracheostomy adapter
• Endotracheal tube connection

Some devices operate manually, allowing the clinician or caregiver to switch between insufflation and exsufflation. Other devices can be set to automatic mode, where the machine cycles through inhalation, exhalation, and pause times according to preset parameters.

Some newer devices also include oscillation during inspiration, expiration, or both. Oscillation may help loosen and mobilize secretions, although the main cough-assist effect still comes from the rapid shift between positive and negative pressure.

Typical Adult Settings

MIE settings should always be individualized. The patient’s diagnosis, tolerance, airway interface, secretion burden, lung mechanics, and response to therapy all matter.

Common adult therapeutic pressures are often in the range of +30 to +50 cm H₂O for insufflation and −30 to −50 cm H₂O for exsufflation. Many adult studies describe approximately +40/−40 cm H₂O as an effective range, but this does not mean every patient should start there.

A typical insufflation time may be 1 to 3 seconds. A typical exsufflation time may also be 1 to 3 seconds, though some sources describe exsufflation lasting 2 to 3 seconds. A pause or rest period may be included between cycles.

A common treatment sequence may include about four to six insufflation-exsufflation cycles. After these cycles, the patient is encouraged to cough or secretions are removed by suctioning. The patient then rests and resumes normal spontaneous or assisted breathing before another set is performed.

Note: The sequence may be repeated several times until secretions are cleared, the patient improves clinically, or the therapy is no longer tolerated.

Starting Low and Titrating Up

One of the most important safety principles in MIE is to start with lower pressures and gradually increase as needed. Initial pressures may begin around +10/−10 cm H₂O or +10 to +15 cm H₂O, depending on the patient and protocol. Pressures are then titrated upward based on comfort, chest expansion, secretion movement, breath sounds, oxygen saturation, and overall response.

For patients with severe restrictive disease or neuromuscular weakness who cannot take deep breaths, gradual pressure increases are especially important. A sudden jump to high pressures may cause discomfort or chest wall muscle strain. Starting low allows the patient to adjust to the sensation of insufflation and exsufflation.

Note: The clinician should use the lowest effective pressure that produces adequate secretion clearance. Higher pressure is not automatically better. The goal is effective expiratory flow and mucus movement without causing avoidable discomfort or complications.

Typical Treatment Procedure

A typical MIE treatment begins with patient assessment. The clinician evaluates the patient’s cough strength, breath sounds, secretion burden, oxygen saturation, respiratory rate, work of breathing, comfort, and airway interface. If the patient uses an artificial airway, the clinician also assesses cuff status and suction needs.

The equipment should be checked before use. The circuit is connected, the filter is in place, and the device is tested. Some procedures include occluding the circuit briefly and toggling between inhalation and exhalation to confirm that the device reaches the desired pressures.

Next, the interface is applied. For noninvasive use, this may be a mask or mouthpiece. For an artificial airway, the device may connect to a tracheostomy tube or endotracheal tube using an appropriate adapter.

The clinician begins with low pressures and adjusts the settings based on tolerance and effectiveness. The device delivers positive pressure for the selected insufflation time, then switches rapidly to negative pressure for the selected exsufflation time. Several cycles are performed. After the set, the patient coughs, expectorates, or is suctioned.

The patient is allowed to rest between sets. This rest period is important because repeated cycles can cause hyperventilation, fatigue, or discomfort. The treatment is repeated as needed until secretions are cleared or the patient has reached a safe stopping point.

Note: After treatment, the patient is reassessed. The clinician documents secretion amount and character, breath sounds, oxygen saturation, patient tolerance, cough effectiveness, adverse effects, and changes in respiratory status.

Suctioning and Secretion Removal

MIE helps move secretions, but it does not always remove them completely from the airway. Some patients can spit secretions out after treatment. Others may need oral, nasopharyngeal, tracheal, or endotracheal suctioning.

This is especially important for patients with artificial airways or severe weakness. MIE may mobilize mucus into a more central location, but suctioning may still be needed to remove the mucus from the tracheostomy tube, airway opening, or mouth.

Note: Clinicians should be ready to suction during and after treatment if secretions are mobilized but not cleared. In some treatment plans, a set of MIE breaths is followed routinely by suctioning, then repeated several times.

Troubleshooting Leaks

Leaks are one of the most common practical problems during mechanical insufflation-exsufflation. If the machine cannot reach the desired positive or negative pressure, a leak should be suspected.

With a mouthpiece, air may leak through the nose. Nose clips may help, or the patient may need a face mask instead. With a face mask, the seal may need adjustment. Facial hair, poor mask fit, patient movement, or discomfort can all interfere with pressure delivery.

For patients with a tracheostomy or endotracheal tube, a leak may occur around the cuff. The cuff should be checked to ensure proper inflation if cuffed airway use is appropriate. Circuit connections, filters, tubing, and adapters should also be inspected.

Note: A leak can reduce the effectiveness of both insufflation and exsufflation. If the patient is not receiving adequate pressure, the device may not generate enough airflow to clear secretions.

Contraindications and Precautions

Mechanical insufflation-exsufflation uses substantial pressure changes, so it is not appropriate for every patient. Contraindications commonly include a history of bullous emphysema, susceptibility to pneumothorax, previous barotrauma, pneumomediastinum, or recent pneumothorax.

These conditions matter because positive pressure can increase the risk of alveolar overdistention or air leak in vulnerable lungs. Negative pressure changes may also be poorly tolerated in certain patients.

MIE should be used cautiously in patients with known cardiac instability. Monitoring heart rate and oxygen saturation may be helpful during therapy, especially in fragile patients or those receiving MIE for the first time.

Other concerns include abdominal distention, discomfort, airway irritation, hemoptysis, and pneumothorax. If hemoptysis or pneumothorax occurs or is suspected, the treatment should be stopped and the physician should be notified.

Managing Abdominal Distention

Abdominal distention can occur if air enters the stomach during insufflation. This may cause discomfort and may reduce patient tolerance. If abdominal distention develops, the insufflation pressure should be decreased.

This is an important distinction. The problem is usually related to air being pushed into the stomach during the positive-pressure phase, so reducing insufflation pressure is the preferred adjustment. Lowering exsufflation pressure may reduce cough effectiveness without addressing the cause of gastric insufflation.

Note: The clinician should also evaluate the mask fit, patient position, pressure settings, and timing. Using the lowest effective insufflation pressure can help reduce this risk.

When MIE May Be Less Effective

MIE is most effective when the airway is open and secretions can be moved outward by airflow. It may be less effective when there is fixed airway obstruction or glottic collapse during exsufflation. This can occur in some patients with bulbar dysfunction, such as bulbar ALS.

If the upper airway collapses during exsufflation, negative pressure may not generate effective expiratory flow from the lungs. The clinician may notice poor secretion movement, poor airflow, discomfort, or failure to achieve expected results.

Note: In these situations, the treatment plan may need to be adjusted. Interface selection, pressure settings, timing, patient positioning, suctioning, and alternative airway clearance methods may need to be considered.

MIE Compared With Manually Assisted Cough

Manually assisted cough techniques can help patients with weak expiratory muscles by applying abdominal or thoracic pressure during exhalation. These techniques can be useful, especially when caregivers are trained properly.

However, MIE offers an advantage because it helps with both the inspiratory and expiratory components of cough. The insufflation phase helps provide a deep breath, while the exsufflation phase produces a rapid expiratory flow. This can be especially helpful when patients have both inspiratory and expiratory muscle weakness.

Note: In many cases, manually assisted cough and MIE are not competing therapies. They may be combined or selected based on patient needs, caregiver skill, equipment availability, and clinical response.

Clinical Goals of MIE

The main goals of mechanical insufflation-exsufflation are to improve secretion clearance and reduce complications caused by retained secretions. A successful treatment may produce visible secretion removal, improved breath sounds, better aeration, improved oxygen saturation, reduced work of breathing, and improved patient comfort.

MIE may also help reduce the frequency of respiratory infections or episodes of atelectasis in selected patients with neuromuscular disease. During acute illness, it can help patients manage increased secretions that they would otherwise be unable to clear.

Note: The therapy should always be evaluated by outcomes. The question is not simply whether the machine was used. The question is whether the patient’s cough effectiveness and secretion clearance improved.

Documentation After Treatment

Proper documentation is important after MIE therapy. The clinician should record the interface used, pressure settings, inspiratory and expiratory times, number of cycles, number of sets, patient position, oxygen use if applicable, suctioning performed, secretion amount and appearance, patient tolerance, and any adverse effects.

Clinical outcomes should also be documented. These may include changes in breath sounds, oxygen saturation, respiratory rate, work of breathing, cough effectiveness, and subjective comfort.

If the patient could not tolerate therapy, the reason should be noted. Examples include discomfort, air leak, abdominal distention, oxygen desaturation, heart rate changes, anxiety, poor mask fit, or inability to coordinate with the device.

Board Exam Takeaways

For exam purposes, mechanical insufflation-exsufflation should be strongly associated with weak cough, neuromuscular disease, neurologic impairment, spinal cord injury, and retained secretions.

A classic exam scenario may describe a patient with spinal cord injury or neuromuscular disease who cannot clear secretions and has a peak cough flow less than 270 L/min. In that case, MIE is often the best airway clearance option.

Important numbers to remember include:

• Peak cough flow less than 270 L/min suggests the need for cough-assist therapy in neuromuscular disease
• Peak cough flow less than 180 L/min indicates a very weak cough
• MEP less than 60 cm H₂O suggests poor expiratory muscle strength
• Common adult MIE pressures are often around +30 to +50 and −30 to −50 cm H₂O
• Many adult protocols use approximately +40/−40 cm H₂O when tolerated
• Treatments commonly include about four to six cycles followed by rest and secretion removal

Note: Remember the major safety concerns. Stop the treatment if hemoptysis or pneumothorax occurs or is suspected. Avoid or use extreme caution in patients with bullous emphysema, recent barotrauma, pneumothorax risk, or cardiac instability.

Mechanical Insufflation-Exsufflation Practice Questions

1. What is mechanical insufflation-exsufflation?
Mechanical insufflation-exsufflation is an airway clearance therapy that provides an artificial cough by alternating positive pressure and negative pressure at the airway.

2. What is another name for mechanical insufflation-exsufflation?
Mechanical insufflation-exsufflation may also be called MIE, MI-E, cough assist, or in-exsufflation.

3. What is the main purpose of MIE?
The main purpose of MIE is to help patients clear retained secretions when they cannot generate an effective cough on their own.

4. How does MIE create an artificial cough?
MIE delivers positive pressure to inflate the lungs, then rapidly switches to negative pressure to create a forceful expiratory flow that moves secretions outward.

5. What does the insufflation phase of MIE do?
The insufflation phase delivers positive pressure to help the patient take a deep breath.

6. What does the exsufflation phase of MIE do?
The exsufflation phase applies negative pressure to rapidly pull air out of the lungs and simulate the expiratory phase of a cough.

7. Why is MIE useful for patients with neuromuscular disease?
MIE is useful because patients with neuromuscular disease often have weak respiratory muscles and cannot cough forcefully enough to clear secretions.

8. What type of patients are most commonly associated with MIE use?
MIE is most commonly used for patients with neuromuscular weakness, neurologic impairment, spinal cord injury, or ineffective cough.

9. What are examples of neuromuscular conditions that may require MIE?
Examples include amyotrophic lateral sclerosis, spinal muscular atrophy, Duchenne muscular dystrophy, myasthenia gravis, poliomyelitis, and spinal cord injury.

10. What is the key adult peak cough flow threshold for considering cough-assist therapy?
A peak cough flow less than 270 L/min is an important threshold for considering cough-assist therapy in adults with neuromuscular disease.

11. What does a peak cough flow below 180 L/min suggest?
A peak cough flow below 180 L/min suggests that the patient may not be able to generate an effective cough.

12. What bedside measurement may be used as a practical equivalent of peak cough flow?
A bedside peak flow measurement may be used as a practical equivalent of peak cough flow.

13. What maximal expiratory pressure value suggests poor cough ability?
A maximal expiratory pressure less than 60 cm H₂O suggests poor expiratory muscle strength and weak cough ability.

14. Why can retained secretions be dangerous?
Retained secretions can obstruct airways, cause atelectasis, worsen oxygenation, increase work of breathing, create V/Q imbalance, and contribute to infection.

15. What are the major phases of a normal cough?
A normal cough includes deep inspiration, glottic closure with compression, and forceful expulsion of air.

16. Why is deep inspiration important before coughing?
Deep inspiration increases lung volume and prepares the lungs for a forceful expiratory effort.

17. What happens during the compression phase of a cough?
During compression, the glottis closes and expiratory muscles create high intrathoracic pressure.

18. What happens when the glottis opens during a cough?
When the glottis opens, air exits rapidly and creates high-velocity airflow that helps move mucus out of the airways.

19. Which components are needed for an effective cough?
An effective cough requires adequate inspiratory strength, expiratory strength, glottic function, and airway patency.

20. What happens if a patient cannot inhale deeply enough before coughing?
If a patient cannot inhale deeply enough, the cough may be weak because there is not enough lung volume to generate strong expiratory flow.

21. What happens if a patient cannot exhale forcefully enough?
If a patient cannot exhale forcefully enough, secretions may remain in the airways and increase the risk of complications.

22. How does MIE help patients with both inspiratory and expiratory muscle weakness?
MIE helps by providing positive pressure for a deep breath and negative pressure for a forceful expiratory flow.

23. What adult MIE pressure range is commonly used for insufflation?
A common adult insufflation pressure range is +30 to +50 cm H₂O.

24. What adult MIE pressure range is commonly used for exsufflation?
A common adult exsufflation pressure range is −30 to −50 cm H₂O.

25. What adult pressure setting is often considered effective in many studies?
A pressure setting around +40/−40 cm H₂O is often considered effective in many adult studies, when tolerated.

26. How many insufflation-exsufflation cycles are commonly given in one set?
A common set includes about four to six insufflation-exsufflation cycles.

27. What usually happens after a set of MIE cycles?
After a set of MIE cycles, the patient is encouraged to cough, expectorate, or have secretions removed by suctioning.

28. Why should patients rest between MIE sets?
Rest periods help reduce the risk of hyperventilation, fatigue, and discomfort during repeated MIE cycles.

29. What is a typical insufflation time during MIE?
A typical insufflation time is about 1 to 3 seconds.

30. What is a typical exsufflation time during MIE?
A typical exsufflation time is about 1 to 3 seconds, although some protocols may use 2 to 3 seconds.

31. Why should MIE pressures usually start low?
MIE pressures should start low to assess patient tolerance and reduce the risk of discomfort, strain, or complications.

32. What is an example of a low starting pressure for MIE?
An example of a low starting pressure is +10/−10 cm H₂O or approximately 10 to 15 cm H₂O.

33. How should MIE pressures be adjusted?
MIE pressures should be gradually increased based on patient tolerance, chest expansion, secretion movement, and clinical response.

34. What is the goal when selecting MIE pressure settings?
The goal is to use the lowest effective pressure that clears secretions safely and comfortably.

35. Why might high pressures not be appropriate at the start of therapy?
High pressures may cause discomfort, poor tolerance, chest wall muscle strain, or increased risk in vulnerable patients.

36. What patient interface may be used for noninvasive MIE?
Noninvasive MIE may be delivered through a face mask, oronasal mask, or mouthpiece.

37. How can MIE be delivered to a patient with an artificial airway?
MIE can be connected to a tracheostomy tube or endotracheal tube using an appropriate adapter.

38. What equipment is commonly part of an MIE system?
An MIE system commonly includes a control unit, compressor, tubing, filter, and patient interface.

39. What controls may be found on an MIE device?
An MIE device may include controls for mode, pressure, inspiratory flow, inhalation time, exhalation time, pause time, and pressure display.

40. What is the purpose of a filter in the MIE circuit?
The filter helps protect the device and circuit from contamination during treatment.

41. What may indicate a system leak during MIE?
Failure to reach the desired positive or negative pressure may indicate a system leak.

42. What should be checked if a mouthpiece patient has a leak?
The clinician should check for air leaking through the nose and may consider nose clips or switching to a face mask.

43. What should be checked if a tracheostomy patient has a leak during MIE?
The cuff should be checked to ensure it is properly inflated, if cuff inflation is appropriate.

44. Why can leaks reduce MIE effectiveness?
Leaks reduce pressure delivery and may prevent the device from generating enough airflow to mobilize secretions.

45. What are common contraindications for MIE?
Common contraindications include bullous emphysema, susceptibility to pneumothorax, recent barotrauma, pneumomediastinum, or recent pneumothorax.

46. Why is bullous emphysema a concern with MIE?
Bullous emphysema is a concern because pressure changes may increase the risk of alveolar rupture or pneumothorax.

47. What should be done if hemoptysis occurs during MIE?
The treatment should be stopped and the physician should be notified.

48. What should be done if pneumothorax is suspected during MIE?
MIE should be stopped immediately and the physician should be notified.

49. Why should MIE be used cautiously in patients with cardiac instability?
MIE can affect intrathoracic pressure and patient tolerance, so heart rate and oxygen saturation may need monitoring.

50. What monitoring may be helpful during MIE?
Monitoring heart rate, oxygen saturation, respiratory status, comfort, and secretion clearance may be helpful during therapy.

51. What is abdominal distention during MIE usually related to?
Abdominal distention during MIE is usually related to air entering the stomach during the positive-pressure insufflation phase.

52. What setting should be reduced if abdominal distention occurs during MIE?
The insufflation pressure should be reduced if abdominal distention occurs.

53. Why should exsufflation pressure not be the first setting reduced for abdominal distention?
Exsufflation pressure should not be reduced first because abdominal distention is usually caused by positive pressure forcing air into the stomach.

54. What is the main clinical goal of MIE?
The main clinical goal of MIE is to improve secretion clearance in patients who cannot cough effectively.

55. What outcomes may suggest that MIE was effective?
Improved breath sounds, visible secretion removal, better aeration, improved oxygen saturation, reduced work of breathing, and improved comfort may suggest effectiveness.

56. Why should MIE be evaluated by patient response rather than simply by whether it was performed?
MIE should be evaluated by response because the goal is improved cough effectiveness and secretion clearance, not just completion of the procedure.

57. What type of airway problem may reduce the effectiveness of MIE?
Fixed airway obstruction may reduce the effectiveness of MIE.

58. How can glottic collapse affect MIE?
Glottic collapse during exsufflation can prevent effective expiratory airflow and reduce secretion clearance.

59. In which condition may bulbar dysfunction interfere with MIE?
Bulbar ALS may interfere with MIE because glottic collapse can occur during exsufflation.

60. Why is airway patency important during MIE?
Airway patency is important because secretions must be moved outward by airflow through an open airway.

61. How does MIE differ from a mucus-loosening therapy?
MIE is designed to simulate a cough by generating inspiratory volume and expiratory flow, rather than only loosening mucus.

62. How does MIE compare with manually assisted cough?
MIE can assist both inspiration and expiration, while manually assisted cough mainly supports forceful exhalation.

63. When might manually assisted cough and MIE be used together?
They may be used together when a patient needs additional support to improve cough flow and secretion clearance.

64. Why may MIE be helpful during an acute illness in a patient with neuromuscular disease?
During acute illness, secretion production may increase, and MIE can help the patient clear secretions despite weak respiratory muscles.

65. What complication can occur when weak cough leads to retained secretions?
Retained secretions can contribute to atelectasis, pneumonia, airway obstruction, and worsening oxygenation.

66. What does MIE provide for patients who cannot periodically take deep breaths?
MIE provides mechanical insufflation to help inflate the lungs and deliver a larger breath before exsufflation.

67. Why might patients with neuromuscular disease lose cough effectiveness before losing resting ventilation?
Cough requires stronger inspiratory and expiratory muscle performance than quiet breathing, so cough may weaken earlier.

68. What does MIE not replace when chronic hypoventilation is present?
MIE does not replace ventilatory support when the main problem is chronic hypoventilation.

69. What findings may suggest a neuromuscular patient needs ventilatory support in addition to MIE?
Rising PaCO₂, declining vital capacity, dyspnea, orthopnea, and daytime drowsiness may suggest the need for ventilatory support.

70. What is the role of suctioning after MIE?
Suctioning removes secretions that MIE has mobilized but the patient cannot expectorate independently.

71. Why may suctioning be especially important for patients with artificial airways?
Patients with artificial airways may not be able to clear mobilized mucus from the tube or airway opening without suctioning.

72. What should be documented after MIE therapy?
Documentation should include settings, interface, number of cycles, secretion amount and appearance, suctioning, patient tolerance, and clinical response.

73. What respiratory findings should be reassessed after MIE?
Breath sounds, oxygen saturation, respiratory rate, work of breathing, cough effectiveness, and comfort should be reassessed.

74. What should be done if the patient cannot tolerate MIE?
The reason for poor tolerance should be identified, therapy should be adjusted or stopped as needed, and the response should be documented.

75. What is a common board-exam clue that points toward MIE?
A patient with neuromuscular weakness, retained secretions, ineffective cough, and low peak cough flow is a common clue for MIE.

76. What is the primary reason MIE is classified as an airway clearance therapy?
MIE is classified as an airway clearance therapy because it helps mobilize and remove retained secretions from the airways.

77. Why is MIE especially helpful when directed cough is ineffective?
MIE is helpful because it mechanically creates the deep inspiration and forceful expiratory flow that the patient cannot produce voluntarily.

78. What does the positive-pressure phase of MIE imitate?
The positive-pressure phase imitates the deep inspiratory phase that occurs before a normal cough.

79. What does the rapid pressure reversal in MIE imitate?
The rapid pressure reversal imitates the forceful expiratory phase of a normal cough.

80. Why can weak breathing muscles develop in patients on long-term ventilatory support?
Weak breathing muscles may develop because of disease progression, poor nutrition, or disuse during mechanical ventilation.

81. What airway clearance methods may be tried before MIE?
Positioning, breathing control, directed cough, manually assisted cough, chest physical therapy, PEP therapy, and suctioning may be tried before MIE.

82. Why may MIE be selected when other airway clearance methods are insufficient?
MIE may be selected when the patient still cannot generate enough cough flow to clear secretions effectively.

83. What does a peak cough flow measurement help determine?
A peak cough flow measurement helps determine whether the patient can generate enough cough strength for effective secretion clearance.

84. Why is a peak cough flow less than 270 L/min important in neuromuscular disease?
It suggests the patient may need cough-assist techniques because cough flow may be too weak for reliable secretion clearance.

85. Why is a peak cough flow less than 180 L/min especially concerning?
It indicates a very weak cough and suggests the patient may be unable to clear secretions effectively, especially during illness.

86. What does a mean MIE cough flow of 7.5 L/sec suggest?
It suggests that MIE can generate expiratory cough flows in the normal range for some patients.

87. Why is it important that expiratory flow remains high immediately after exsufflation?
It suggests that MIE does not necessarily promote airway collapse during the expiratory phase.

88. What is the purpose of a pause time during automatic MIE?
The pause time allows a brief rest between insufflation-exsufflation cycles and helps the patient tolerate repeated cycles.

89. Why might oscillation be added to some MIE devices?
Oscillation may be added to help loosen and mobilize secretions during inspiration, expiration, or both.

90. What should the clinician assess before starting MIE?
The clinician should assess cough strength, secretion burden, breath sounds, oxygen saturation, respiratory status, airway interface, and patient tolerance.

91. Why is patient comfort important during MIE?
Patient comfort is important because poor tolerance can limit the effectiveness and safety of therapy.

92. Why should MIE settings be individualized?
Settings should be individualized because patients differ in size, disease severity, airway interface, lung mechanics, secretion burden, and tolerance.

93. Why may patients with severe restrictive disease need gradual pressure increases?
They may not tolerate large insufflation volumes immediately, and gradual increases help reduce discomfort or chest wall muscle strain.

94. What is the role of MIE in preventing atelectasis?
MIE can help remove retained secretions and provide lung inflation, which may reduce the risk of airway obstruction and atelectasis.

95. What is the role of MIE in preventing pneumonia?
MIE may help reduce pneumonia risk by improving secretion clearance in patients who cannot cough effectively.

96. Why is MIE not considered a treatment for chronic hypoventilation by itself?
MIE clears secretions but does not provide ongoing ventilatory support for patients who cannot maintain adequate ventilation.

97. What signs may show that MIE improved airway clearance?
Less rhonchi, improved aeration, easier breathing, improved oxygen saturation, and removal of secretions may show improvement.

98. What should be done after MIE mobilizes secretions into the upper airway?
The secretions should be expectorated, swallowed if appropriate, or removed by suctioning.

99. What is the key exam connection between spinal cord injury and MIE?
Spinal cord injury can weaken cough muscles, causing retained secretions and low peak cough flow, which may indicate MIE.

100. What is the most important takeaway about MIE?
MIE should be considered when a patient has ineffective cough, retained secretions, and neuromuscular or neurologic weakness that limits airway clearance.

Final Thoughts

Mechanical insufflation-exsufflation is an important airway clearance therapy for patients who cannot generate an effective cough. By delivering positive pressure followed by rapid negative pressure, it helps simulate the inspiratory and expiratory phases of coughing.

This makes it especially useful for patients with neuromuscular disease, spinal cord injury, and other conditions that weaken respiratory muscles. Safe use requires careful patient selection, gradual pressure titration, monitoring, suctioning when needed, and awareness of contraindications.

When used appropriately, MIE can help remove retained secretions, reduce respiratory complications, and support patients who cannot cough strongly on their own.